A Study of Switch From Nucleotide to Peginterferon Alfa-2a in CHB Patients Achieving HBeAg Loss and HBV DNA <200IU/ml
Clinical trial NCT01464281 · UNKNOWN
Trial details
- NCT number
- NCT01464281
- Sponsor
- The Second Affiliated Hospital of Chongqing Medical University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2016-06-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.